Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
| NAV as of Oct 20, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
|---|---|---|---|
| ₹13.821+0.61% 1 day change | 18.76% p.a. | App exclusive | ₹464 Cr |
| AUM (Fund size) | ₹464 Cr |
| Exit load | 0.5% 0.5% for redemption within 30 Days! |
| Lock-in Period | Nil |
| Age | 1 yrs 11 m since Nov 20, 2023 |
| Benchmark | NIFTY Healthcare TRI. |
| Min. investment | SIP: ₹500 & Lumpsum: ₹1000 |
| Expense ratio | 2.4% as on Sep 30, 2025 |
| Plan type | Regular |
| Risk | Very High |
| Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
| Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
| Period | This fund | Category average |
|---|---|---|
| 1 Month | 3.14% | 2.15% |
| 3 Months | -0.35% | -0.73% |
| 6 Months | 7.72% | 7.45% |
| 1 Year | 4.15% | 4.27% |

Large Cap 45.88%
Mid Cap 16.63%
Small Cap 35.17%
Other Cap 0%
Healthcare 97.68%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Repo 2.56%
Others 2.56%

| Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|
| Kotak Healthcare Fund | 3.14% | 7.72% | 4.15% | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 1.8% | 9.49% | 7.55% | 27.92% | 20.98% | 15.16% |
| SBI Healthcare Opportunities Fund | 2.93% | 5.7% | 7.57% | 25.5% | 20.14% | 11.0% |
| DSP Healthcare Fund | 2.27% | 6.86% | 0.02% | 22.71% | 18.11% | 14.77% |
| Tata India Pharma & Healthcare Fund | 1.98% | 6.5% | 2.98% | 22.6% | 18.43% | 11.98% |
| Nippon India Pharma Fund | 1.55% | 4.62% | 2.0% | 21.83% | 18.23% | 12.7% |
| Fund name | Std. deviation | Beta | Sharpe | Sortino |
|---|---|---|---|---|
| Kotak Healthcare Fund | N.A. | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.66 | 0.95 | 1.2 | 1.74 |
| SBI Healthcare Opportunities Fund | 14.07 | 0.84 | 1.19 | 1.86 |
| DSP Healthcare Fund | 14.67 | 0.84 | 1.03 | 1.8 |
| Tata India Pharma & Healthcare Fund | 16.05 | 0.97 | 0.92 | 1.47 |
| Nippon India Pharma Fund | 15.22 | 0.91 | 0.9 | 1.39 |
| Fund name | ETM Rank | AUM | Fund age | Expense ratio |
|---|---|---|---|---|
| Kotak Healthcare Fund | N.A. | 464 Cr | 1 yrs 11 m | 2.4% |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 6,227 Cr | 7 yrs 4 m | 1.87% |
| SBI Healthcare Opportunities Fund | N.A. | 3,933 Cr | 26 yrs 4 m | 1.93% |
| DSP Healthcare Fund | N.A. | 3,074 Cr | 6 yrs 11 m | 1.93% |
| Tata India Pharma & Healthcare Fund | N.A. | 1,296 Cr | 9 yrs 10 m | 2.1% |
| Nippon India Pharma Fund | N.A. | 8,114 Cr | 21 yrs 5 m | 1.82% |
Risk ratios are based on three-year data. The required data is unavailable for the scheme.
| Fund AUM | 464 Cr as on Sep 30, 2025 |
| Scheme document | View Scheme Document |
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
| No. of schemes | 83 view all schemes |
| Total AUM | 5,66,982 Cr as on Sep 30, 2025 |
| Address | The Capital Building, Behind ICICI Bank, G Block BKC, Bandra Kurla Complex Bandra (E) Mumbai, 400051 |
| Phone | 022-61152100 / 1800-22-2626 |
| Fund name | ETM Rank | AUM | 1Y | 5Y |
|---|---|---|---|---|
| Kotak Infrastructure and Economic Reform Fund | N.A. | 2,341 Cr | 0.88% | 30.85% |
| Kotak Midcap Fund | N.A. | 58,300 Cr | 7.05% | 27.34% |
| Kotak Small Cap Fund | N.A. | 17,480 Cr | -3.38% | 26.32% |
| Kotak Contra Fund | N.A. | 4,716 Cr | 5.83% | 23.56% |
| Kotak Pioneer Fund | N.A. | 3,148 Cr | 10.06% | 23.28% |
| Kotak Large & Midcap Fund | N.A. | 28,381 Cr | 6.11% | 22.34% |
The current Net Asset Value (NAV) of the Kotak Healthcare Fund plan is approximately ₹13.821 as of Oct 20, 2025.
The Kotak Healthcare Fund is a 1 yrs 11 m old fund and has delivered average annual returns of 18.76% since inception.
| 1-Year | Since Inception |
|---|---|
| 4.15% | 18.76% |
The Kotak Healthcare Fund has an expense ratio of 2.4%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The Kotak Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 464 Cr as on Sep 30, 2025.
The Kotak Healthcare Fund has invested the majority of its money in the stocks of the following companies -
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 13.05% |
| Max Healthcare Institute Ltd. | 7.33% |
| JB Chemicals & Pharmaceuticals Ltd. | 5.93% |
| Cipla Ltd. | 5.51% |
| Divi's Laboratories Ltd. | 4.9% |
| Apollo Hospitals Enterprise Ltd. | 4.23% |
| Fortis Healthcare Ltd. | 4.18% |
| Lupin Ltd. | 3.91% |
| Jubilant Pharmova Ltd. | 3.26% |
| Krishna Institute of Medical Sciences Ltd | 3.02% |
The Kotak Healthcare Fund has primarily invested in the following sectors
| Sector | Percentage of Portfolio |
|---|---|
| Healthcare | 97.68% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
Redeeming your investments in the Kotak Healthcare Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.
